EUVIMEDEUVIMED entdecken
Open Access

Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis

Galina S Bogatkevich iD, Ilia Atanelishvili, Andrew M Bogatkevich, Richard M Silver iD

Arthritis & Rheumatology · 2023

DOI: 10.1002/art.42344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2023. Verfasst von Galina S Bogatkevich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Scleroderma, Systemic, Lung Diseases, Interstitial, Scleroderma, Localized. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Scleroderma Foundation, NIAMS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Interstitial lung disease (ILD) is a serious complication and leading cause of mortality in patients with systemic sclerosis (SSc). In this study, we explored the role of LIM and cysteine‐rich domains protein 1 (LMCD1) as a novel factor in the pathogenesis of SSc‐related ILD (SSc‐ILD).

Methods

The expression and effects of LMCD1 were studied in lung tissue samples and fibroblasts from SSc‐ILD patients and control subjects as well as in lung tissue samples from animal models.

Results

LMCD1 was consistently elevated in lung tissue samples and in fibroblasts isolated from SSc‐ILD patients as compared to controls. Additionally, LMCD1 was found to be highly expressed in the lung in the fibroblast‐specific protein (FSP)–driven, constitutively active transforming growth factor β receptor type I (TGFβR1) transgenic mouse model of ILD and the bleomycin‐induced mouse model of ILD. In lung fibroblasts from SSc‐ILD patients, LMCD1 is an essential factor for the TGFβ‐induced generation of type I collagen, fibronectin, and α‐smooth muscle actin (α‐SMA). Depletion of LMCD1 by small interfering RNA reduced the expression of extracellular matrix proteins and lowered transcriptional activity and expression of α‐SMA, as well as decreased the proliferation and contractile activity of SSc‐ILD lung fibroblasts. In dense fibrotic areas of affected lung tissue, lung LMCD1 colocalized with α‐SMA. In cultured scleroderma lung fibroblasts, LMCD1 colocalized and interacted with serum response factor which mediates LMCD1‐induced contractile activity of lung fibroblasts.

Conclusion

Our study identifies LMCD1 as a profibrotic molecule contributing to the activation of myofibroblasts and the persistent fibroproliferation observed in SSc‐ILD. Thus, LMCD1 may be a potential novel therapeutic target for patients with SSc‐ILD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisScleroderma, SystemicLung Diseases, InterstitialScleroderma, LocalizedAnimalsMiceMyofibroblastsLungFibroblastsCo-Repressor ProteinsLIM Domain Proteins

Substanzen

Lmcd1 protein, mouseCo-Repressor ProteinsLIM Domain Proteins

Autor:innen und Institutionen

  • Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston.
  • Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, and College of Charleston (BSc Student), Charleston, South Carolina.

ORCID-Profile: Galina S Bogatkevich, Richard M Silver

Förderung

  • National Scleroderma Foundation
  • NIAMS NIH HHS
  • NIGMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Bogatkevich, G. S., Atanelishvili, I., Bogatkevich, A. M., & Silver, R. M. (2023). Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis. Arthritis & Rheumatology. https://doi.org/10.1002/art.42344

Vancouver

Bogatkevich GS, Atanelishvili I, Bogatkevich AM, Silver RM. Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis. Arthritis & Rheumatology. 2023. doi:10.1002/art.42344

BibTeX
@article{Bogatkevich2023,
  author = {Bogatkevich, Galina S and Atanelishvili, Ilia and Bogatkevich, Andrew M and Silver, Richard M},
  title = {Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  doi = {10.1002/art.42344}
}
Kostenlos starten →